Hibernia Wealth Partners’s CVS Health CVS Stock Holding History

Hibernia Wealth Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-64	Closed	-$4.47K	–	128
2023 Q3	$4.47K	Buy	+64	New	+$4.54K	﹤0.01%	214

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hibernia Wealth Partners's CVS Position: Q4 2023 in Review

Hibernia Wealth Partners sold out of CVS Health (CVS) in Q4 2023, closing a stake of 64 shares — an estimated $4.47K sold.

Hibernia Wealth Partners first reported a position in CVS in Q3 2023 and held it in 1 quarter. The position peaked at $4.47K in Q3 2023. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

Hibernia Wealth Partners reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
Hibernia Wealth Partners sold 64 CVS Health shares in Q4 2023, an estimated $4.47K.
Hibernia Wealth Partners first reported a position in CVS Health in Q3 2023 and held it in 1 quarter.
Hibernia Wealth Partners's CVS Health position peaked at $4.47K in Q3 2023.
2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Hibernia Wealth Partners's 13F filing for Q4 2023, filed 19 Jan 2024.